Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

CMAJ. Canadian Medical Association Journal

Volumn 179, Issue 8, 2008, Pages 767-772

  Dial, Sandra ^a,c   Kezouh, Abbas ^b   Dascal, Andre ^a,b   Barkun, Alan ^a,d   Suissa, Samy ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GATIFLOXACIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LEVOFLOXACIN; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PROTON PUMP INHIBITOR; TETRACYCLINE; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG USE; ENTERITIS; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GROUPS BY AGE; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION RISK; IRRITABLE COLON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCRIPTION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TREATMENT DURATION;

EID: 54349091533     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.071812     Document Type: Article

References (28)

1. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006;145:758-64.
2. Kelly CP, Pothoulakis C, Lamont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
3. Wilcox MH, Mooney L, Bendall R, et al A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008;62:388-96. Epub 2008 Apr 22.
4. Dial S, Delaney JA, Schneider V, et al. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ 2006;175:745-8.
5. Dial S, Delaney JA, Barkun AN, et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-95.
6. Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 2007;45:222-7.
7. Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis 2008;46(Suppl 1):S4-11.
8. Dial S, Delaney JA, Barkun AN, et al. Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease - author response [letter]. JAMA 2006;295:2600-1.
9. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992;15:573-81.
10. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-51.
11. Svenungsson B, Lagergren A, Lundberg A. Clostridium difficile cytotoxin B in adults with diarrhea: a comparison of patients treated or not treated with antibiotics prior to infection. Clin Microbiol Infect 2001;7:447-50.
12. Climo MW, Israel DS, Wong ES, et al. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998;128:989-95.
13. Pierce PF Jr, Wilson R, Silva J Jr, et al. Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis 1982;145:269-74.
14. Bartlett JG. Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. Johns Hopkins Med J 1981;149:6-9.
15. Lowe DO, Mamdani MM, Kopp A, et al. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis 2006;43:1272-6.
16. Rahme E, Pettitt D, Lelorier J. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum 2002;46:3046-54.
17. Tamblyn R, Lavoie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995;48:999-1009.
18. Hebert B. Current epidemiology of CDAD in Quebec [presentation]. Proceedings of the International Conference on Clostridium difficile; 2005 Oct 14. Montréal (QC): Institut national de santé publique du Québec; 2005. Available: www.inspq.qc.ca/aspx/docs/ InfectionsNosocomiales/CDifficile/20051014_Cdifficile_Hubert1.pdf (accessed 2008 Jul 11).
19. Hirschhorn LR, Trnka Y, Onderdonk A, et al. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994;169:127-33.
20. McFarland LV, Clarridge JE, Beneda HW, et al. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis 2007;45:1141-51.
21. Kutty PK, Benoit SR, Woods CW, et al. Emerging Clostridium difficile-associated disease in the community and the role of non-antimicrobial risk factors [abstract LB-28]. 45th annual meeting of the Infectious Diseases Society of America; 2007 Oct 4-7; San Diego. p. 242. Available: www.idsociety.org/WorkArea/showcontent.aspx?id=2080 (accessed 2008 Aug 25).
22. Severe Clostridium difficile-associated disease in populations previously at low risk - four states, 2005. MMWR Morb Mortal Wkly Rep 2005;54:1201-5.
23. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254-60.
24. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9.
25. Dubberke ER, Reske KA, McDonald LC, et al. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis 2006;12:1576-9.
26. Scheurer DB, Hicks LS, Cook EF, et al. Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect 2007;135:1010-3. Epub 2006 Dec 7. 27.
27. Vies des générations et personnes âgeés: aujourd'hui et demain. Québec (QC) : Institut de la statistique du Québec; 2007. Available: www.bdso.gouv.qc.ca/docs-ken/multimedia/ PB01614FR_VieGenerationVo2_2007.pdf (accessed 2008 July 11).
28. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004;57:131-41.